Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Two Arrested In Tokyo For Selling ¥170 Million Worth Of Botox Without Permission

This article was originally published in PharmAsia News

Executive Summary

Tokyo based drug importer Forclinic President Kim Tae-hyon and another worker were arrested July 31 for violating the Pharmaceutical Affairs Law and selling drugs containing botulinum toxin without permission. Imported from Hong Kong, the drug has not been approved in Japan. According to the authority, the company sold it to 180 clinics nationwide and the sales totaled ¥170 million within a year. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069483

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel